Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.18
+0.12 (1.98%)
Oct 15, 2025, 1:08 PM EDT - Market open
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $219.72 million as of October 15, 2025. Its market cap has decreased by -62.04% in one year.
Market Cap
219.72M
Enterprise Value
-83.82M
1-Year Change
-62.04%
Ranking
Category
Stock Price
$6.18
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $219.72M, a decrease of -12.47%. That is a compound annual growth rate of -3.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 14, 2025 | 215.45M | -64.80% |
Dec 31, 2024 | 612.16M | 21.70% |
Dec 29, 2023 | 503.01M | 18.72% |
Dec 30, 2022 | 423.70M | -20.71% |
Dec 31, 2021 | 534.36M | 112.88% |
Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 729.28B |
Johnson & Johnson | 459.63B |
AbbVie | 404.77B |
UnitedHealth Group | 325.98B |
AstraZeneca | 262.55B |
Novartis AG | 251.13B |
Novo Nordisk | 248.67B |
Abbott Laboratories | 231.95B |